
Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated April 15, 2025, titled "Dr. Lal PathLabs Becomes South Asia s First Diagnostic Chain to Launch Advanced Test for Amyloidosis".
Filed with NSE ·

Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated April 15, 2025, titled "Dr. Lal PathLabs Becomes South Asia s First Diagnostic Chain to Launch Advanced Test for Amyloidosis".
6ix hasn’t read this filing yet.
Dr. Lal PathLabs Limited on 6ix
Follow Dr. Lal PathLabs into a list and get an email when it puts out news.
Follow Dr. Lal PathLabs